Aeterna Zentaris Inc. (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 16,900 shares, a decrease of 22.1% from the March 31st total of 21,700 shares. Approximately 0.4% of the shares of the company are sold short. […]
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report report published on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Price Performance NASDAQ:AEZS opened at $2.06 on Friday. The firm’s fifty day moving average price is $1.93 and its 200 […]
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reduced their price objective on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the company […]
Investment analysts at StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright dropped their price target on shares of Aeterna Zentaris from $28.00 to $15.00 […]